Skip to main content

MoneyWorks4Me

Biocon informs about press release

28 Jan 2026 Evaluate
Biocon has informed that it enclosed the press release titled ‘S&P Global Upgrades Biocon Biologics Credit Rating To ‘BB+’ Revises Outlook to ‘Stable’. The above information will also be available on the website of the Company at www.biocon.com.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1880.90
Dr. Reddys Labs. 1377.00
Cipla 1393.00
Lupin 1980.00
Zydus Lifesciences 1191.00
View more..